다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (VTYX) 뉴스

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VTYX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/04	08:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2025/01/04	08:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2025/01/04	08:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2025/01/04	08:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/31	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/28	06:46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/20	08:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/20	08:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/20	08:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/12/12	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/26	11:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/16	06:59	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/08	07:13	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/08	06:58	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/08	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/11/08	06:05	GlobeNewswire Inc.	Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Progress	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/10/15	21:00	GlobeNewswire Inc.	Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/10/01	05:40	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/09/23	21:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/09/23	21:00	GlobeNewswire Inc.	Ventyx Biosciences Announces $27 Million Strategic Investment from Sanofi	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/09/10	05:47	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/09/06	21:00	GlobeNewswire Inc.	Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s Disease	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/30	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/30	21:00	GlobeNewswire Inc.	Ventyx Biosciences Announces Departure of Chief Financial Officer	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/28	21:00	GlobeNewswire Inc.	Ventyx Biosciences to Participate in Two Upcoming Investor Conferences	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/14	05:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/14	05:35	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/09	05:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/08/09	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc

검색 관련기사 보기:NASDAQ:VTYX

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Yen

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Financial Select Sector

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관